>
Benchmark diesel price is now highest since war began
Alzheimer's hope: Nanoparticles regenerate cells to restore memory
Wood fire alternative warms your campsite with a red-hot rod
Scientists tested 212 plant-based meat alternatives. Every one contained fungal toxins
Here's What to Expect as Air Taxis Actually Begin to Take Off
'Wood Foam' Startup Uses Logging Waste as Substitute for Plastic, Producing 400 Pounds Daily
How a Group of Young Men in 1933 Solved a Water Crisis in The Desert -- And Nobody Knows About It
This American Battery Could Break China's Grip On The EV Supply Chain
Tesla's Cybercab Launch Is Next Week. Here's What Tesla Still Needs To Prove
800-passenger commercial plane boldly reinvents how we will fly
Does Ultra-Fast Charging Ruin An EV Battery? BYD Did It 350 Times In 9 Days To Find Out
Singapore is experimenting with biological computing using living human neurons...
It's Happening - Europe is Building an Impossible Fusion Reactor
Portable 1MW Kaleidos Microreactor Secures Critical Nuclear Fuel Deal Through 2030s

Authored by Joseph Brown via TheMindUnleashed.com,
The Food and Drug Administration authorized eye drops that may possibly replace reading glasses for millions of people in October, and they entered the market this week.
"It's definitely a life changer," trial participant Toni Wright told CBS.
"I would not need my readers as much, especially on the computer, where I would always need to have them on."
The drops, known as pilocarpine, and sold by pharma outlet Allergan under the name "Vuity," might help the 128 million people in the United States who are nearsighted.
One drop in each eye, according to the business, may enhance closeup eyesight for six to ten hours, according to CBS News.